Veracyte, Inc. VCYT
NASDAQ · United States · Health Technology
$46.33+0.29 (+0.62%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-07-30 | 0.54 | 0.41 | +31.6% | $150.32M | +4.0% | -16.9%$55.71→$46.32 |
| Q1 2026 | 2026-05-05 | 0.37 | 0.23 | +60.9% | — | — | +23.1%$33.45→$41.19 |
| Q4 2025 | 2026-02-25 | 0.53 | 0.41 | +29.3% | — | — | +8.6%$35.69→$38.75 |
| Q3 2025 | 2025-11-04 | 0.38 | 0.19 | +100.0% | — | — | +26.3%$36.45→$46.04 |
| Q4 2024 | 2025-02-24 | 0.36 | 0.26 | +38.5% | — | — | — |
| Q4 2023 | 2024-02-22 | -0.39 | -0.03 | -1,200.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.